Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 94.30% is in line with its 5-year average of 95.52%, near the high end of its 5-year range (-14.74%–96.95%).
0.33% below its 12-month average of 94.62%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 92.41%.
GROSS MARGIN
94.30%
GROSS MARGIN AVG TTM
94.62%
GROSS MARGIN AVG 3Y
95.83%
GROSS MARGIN AVG 5Y
95.52%
GROSS MARGIN AVG 10Y
48.96%
GROSS MARGIN AVG 15Y
50.51%
GROSS MARGIN AVG 20Y
57.31%
CURRENT VS TTM AVG
-0.33%
CURRENT VS 3Y AVG
-1.60%
CURRENT VS 5Y AVG
-1.28%
CURRENT VS 10Y AVG
+92.59%
CURRENT VS 15Y AVG
+86.70%
CURRENT VS 20Y AVG
+64.54%
SECTOR MEDIAN · HEALTHCARE
40.38%
median of 696 covered companies
CURRENT VS SECTOR MEDIAN
+133.53%
vs the sector median at left
Gyre Therapeutics, Inc.
Market Cap
$799.93M
Gross Margin
94.30%
TTM Avg
94.62%
3Y Avg
95.83%
5Y Avg
95.52%
Market Cap
$796.60M
Gross Margin
10.37%
TTM Avg
19.20%
3Y Avg
18.44%
5Y Avg
17.81%
Market Cap
$789.07M
Gross Margin
97.42%
TTM Avg
97.90%
3Y Avg
98.95%
5Y Avg
-3197.94%
Market Cap
$785.87M
Gross Margin
98.85%
TTM Avg
98.73%
3Y Avg
-10570.46%
5Y Avg
-10093.61%
Market Cap
$774.92M
Gross Margin
40.44%
TTM Avg
20.22%
3Y Avg
20.22%
5Y Avg
20.22%
Market Cap
$826.20M
Gross Margin
35.97%
TTM Avg
27.94%
3Y Avg
30.11%
5Y Avg
34.47%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gyre Therapeutics, Inc. (GYRE) | $799.93M | 94.30% | 94.62% | 95.83% | 95.52% |
| AdaptHealth Corp. (AHCO)vs › | $796.60M | 10.37% | 19.20% | 18.44% | 17.81% |
| Apnimed, Inc. (APMD)vs › | $804.20M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $805.59M | 76.52% | 79.43% | 81.57% | 82.72% |
| Geron Corporation (GERN)vs › | $789.07M | 97.42% | 97.90% | 98.95% | -3197.94% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $785.87M | 98.85% | 98.73% | -10570.46% | -10093.61% |
| Ardelyx, Inc. (ARDX)vs › | $817.22M | 93.96% | 87.19% | 88.05% | 90.06% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $774.92M | 40.44% | 20.22% | 20.22% | 20.22% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $826.20M | 35.97% | 27.94% | 30.11% | 34.47% |
| Mesa Laboratories, Inc. (MLAB)vs › | $773.58M | 65.99% | 63.07% | 62.20% | 62.16% |
Gross Margin
94.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 92.41% |
| 2026-03-31 | 94.55% |
| 2025-12-31 | 95.31% |
| 2025-09-30 | 94.67% |
| 2025-06-30 | 96.13% |
| 2025-03-31 | 95.95% |
| 2024-12-31 | 95.78% |
| 2024-09-30 | 96.24% |
| 2024-06-30 | 96.95% |
| 2024-03-31 | 96.40% |
| 2023-12-31 | 95.40% |
| 2023-09-30 | 96.30% |
| 2023-06-30 | 96.33% |
| 2023-03-31 | 95.49% |
| 2022-12-31 | 95.22% |
| 2022-09-30 | 95.23% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | -14.74% |
| 2021-12-31 | -0.57% |
| 2021-09-30 | -4.05% |
| 2021-06-30 | -4.59% |
| 2021-03-31 | -0.89% |
| 2020-12-31 | -2.22% |
| 2020-09-30 | -2.02% |
| 2020-06-30 | -5.07% |
| 2020-03-31 | 72.63% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 137416.67% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | -62750.00% |
| 2017-12-31 | -8978.93% |
| 2017-09-30 | -1096.54% |
| 2017-06-30 | -25765.77% |
| 2017-03-31 | -10000.00% |
| 2016-12-31 | -2874.65% |
| 2016-09-30 | -3015.60% |
| 2016-06-30 | -2424.77% |
| 2016-03-31 | -1997.25% |
| 2015-12-31 | -1520.18% |
| 2015-09-30 | -1263.30% |
| 2015-06-30 | -53.90% |
| 2015-03-31 | -105.65% |
| 2014-12-31 | 16.15% |
| 2014-09-30 | -5244.00% |
| 2014-06-30 | -3475.00% |
| 2014-03-31 | -1334.44% |
| 2013-12-31 | 100.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 100.00% |
| 2012-12-31 | 100.00% |
| 2012-09-30 | 100.00% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | -376.95% |
| 2009-09-30 | 98.37% |
| 2009-06-30 | 90.88% |
| 2009-03-31 | 96.29% |
| 2008-12-31 | 97.17% |
| 2008-09-30 | -41.96% |
| 2008-06-30 | -59.28% |
| 2008-03-31 | -43.90% |
| 2007-12-31 | 95.18% |
| 2007-09-30 | 94.46% |
| 2007-06-30 | 92.78% |
| 2007-03-31 | 91.93% |
| 2006-12-31 | 99.38% |
| 2006-09-30 | 86.78% |
| 2006-06-30 | 103.79% |
| 2006-03-31 | 68.50% |
| 2005-12-31 | 0.68% |
| 2005-09-30 | 63.51% |
| 2005-06-30 | 67.37% |
| 2005-03-31 | 92.56% |
